Methods for treating proliferative diseases and for monitoring the effectiveness of treatment of proliferative diseases

Details for Australian Patent Application No. 2004227103 (hide)

Owner Novartis AG

Inventors Hu, Ping; Batt, David Bryant; Wang, Yingqi Karen

Agent Davies Collison Cave

Pub. Number AU-A-2004227103

PCT Pub. Number WO2004/090545

Priority 60/462,723 14.04.03 US

Filing date 13 April 2004

Wipo publication date 21 October 2004

International Classifications

G01N 033/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/090545 Priority application(s): WO2004/090545

3 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004227111-Methods and means for increasing the tolerance of plants to stress conditions

2004227095-Fuel composition